Sera of Patients With Celiac Disease and Neurologic Disorders Evoke a Mitochondrial-Dependent Apoptosis In Vitro

Gastroenterology

Volumn 133, Issue 1, 2007, Pages 195-206

  Cervio, Elisabetta ^a   Volta, Umberto ^b   Verri, Manuela ^a   Boschi, Federica ^a   Pastoris, Ornella ^a   Granito, Alessandro ^b   Barbara, Giovanni ^b   Parisi, Claudia ^b   Felicani, Cristina ^b   Tonini, Marcello ^a   De Giorgio, Roberto ^b  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 3; CASPASE 3 ANTIBODY; CASPASE 8; CASPASE 9; CYTOCHROME C; GLIADIN ANTIBODY; IMMUNOGLOBULIN G; NEURAL ANTIBODY; PROTEIN BAX; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; UNCLASSIFIED DRUG;

ADSORPTION; ANTIBODY LABELING; APOPTOSIS; ARTICLE; BLOOD CHEMISTRY; CELIAC DISEASE; CELL LABELING; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; ENZYME DEGRADATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MITOCHONDRIAL RESPIRATION; NEUROLOGIC DISEASE; NICK END LABELING; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 34447102105     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.04.070     Document Type: Article

References (44)

1. Green P.H.R., and Jabri B. Coeliac disease. Lancet 362 (2003) 383-391
2. Lock R.J., Pitcher M.C., and Unsworth D.J. IgA anti-tissue transglutaminase as a diagnostic marker of gluten sensitive enteropathy. J Clin Pathol 52 (1999) 274-277
3. Maki M., and Collin P. Coeliac disease. Lancet 349 (1997) 1755-1759
4. Dieterich W., Ehnis T., Bauer M., Donner P., Volta U., Riecken E.O., and Schuppan D. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3 (1997) 797-801
5. Alaedini A., and Green P.H. Narrative review: celiac disease: understanding a complex autoimmune disorder. Ann Intern Med 142 (2005) 289-299
6. Luorostainen L., Pirttila T., and Collin P. Coeliac disease presenting with neurological disorders. Eur Neurol 42 (1999) 132-135
7. Wills A.J. The neurology and neuropathology of coeliac disease. Neuropathol Appl Neurobiol 26 (2000) 493-496
8. Ciclitira P.J. AGA technical review on celiac sprue. Gastroenterology 120 (2001) 1526-1540
9. Pengiran Tengah D.S., Wills A.J., and Holmes G.K. Neurological complications of coeliac disease. Postgrad Med J 78 (2002) 393-398
10. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 119 (2000) 234-242
11. Volta U., De Giorgio R., Petrolini N., Stanghellini V., Barbara G., Granito A., De Ponti F., Corinaldesi R., and Bianchi F.B. Clinical findings and anti-neuronal antibodies in coeliac disease with neurological disorders. Scand J Gastroenterol 37 (2002) 1276-1281
12. Hadjivassiliou M., Grünewald R.A., Chattopadhyay A.K., Davies-Jones G.A., Gibson A., Jarratt J.A., Kandler R.H., Lobo A., Powell T., and Smith C.M. Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet 352 (1998) 1582-1585
13. Hadjivassiliou M., Grünewald R.A., Kandler R.H., Chattopadhyay A.K., Jarratt J.A., Sanders D.S., Sharrack B., Wharton S.B., and Davies-Jones G.A. Neuropathy associated with gluten sensitivity. J Neurol Neurosurg Psychiatry 77 (2006) 1262-1266
14. Wills A.J., Turner B., Lock R.J., Johnston S.L., Unsworth D.J., and Fry L. Dermatitis herpetiformis and neurological dysfunction. J Neurol Neurosurg Psychiatry 72 (2002) 259-261
15. Hadjivassiliou M., Grunewald R.A., and Davies-Jones G.A. Gluten sensitivity as a neurological illness. J Neurol Neurosurg Psychiatry 72 (2002) 560-563
16. Volta U., Molinaro N., De Franceschi L., Fratangelo D., and Bianchi F.B. IgA anti-endomysial antibodies on human umbilical cord tissue for celiac disease screening: save both money and monkeys. Dig Dis Sci 40 (1995) 1902-1905
17. Marsh M.N. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity. Gastroenterology 102 (1992) 330-354
18. Oberhuber G., Granditsch G., and Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepathol 11 (1999) 1185-1194
19. Granito A., Muratori P., Cassani F., Pappas G., Muratori L., Agostinelli D., Veronesi L., Bortolotti R., Petrolini N., Bianchi F.B., and Volta U. Anti-actin IgA antibodies in severe coeliac disease. Clin Exp Immunol 137 (2004) 386-392
20. Migheli A., Attanasio A., Lee W., Bayer S.A., and Ghetti B. Detection of apoptosis in weaver cerebellum by electron microscopic in situ end-labeling of fragmented DNA. Neurosci Lett 199 (1995) 53-56
21. Li X., Traganos F., Melamed M.R., and Darzynkiewicz Z. Single-step procedure for labeling DNA strand breaks with floures. Cytometry 20 (1995) 172-180
22. Junn E., and Mouradian M.M. Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome C and caspases. J Neurochem 78 (2001) 374-383
23. Pastoris O., Dossena M., Vercesi L., Bruseghini M., Pagnin A., and Ceriana P. Biochemical changes induced in the myocardial cell during cardioplegic arrest supplemented with creatine phosphate. J Cardiothorac Vasc Anesth 5 (1991) 475-480
24. Pitti R.M., Marsters S.A., Ruppert S., Donahue C.J., Moore A., and Ashkenazi A. Induction of apoptosis by APO-2 ligand, a new member of the TNF cytokine family. J Biol Chem 271 (1996) 12687-12690
25. Wiley S.R., Schooley K., Smolak P.J., Din W.S., Huang C.P., Nicholl J.K., Sutherland G.R., Smith T.D., Rauch C., Smith C.A., and Goodwin R.G. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3 (1995) 673-682
26. Volta U., De Giorgio R., Granito A., Stanghellini V., Barbara G., Avoni P., Liguori R., Petrolini N., Fiorini E., Montagna P., Corinaldesi R., and Bianchi F.B. Anti-ganglioside antibodies in coeliac disease with neurological disorders. Dig Liver Dis 38 (2006) 183-187
27. Volta U., De Giorgio R., Petrolini N., Stanghellini V., Barbara G., Granito A., Veronesi L., De Ponti F., Fustini E., Corinaldesi R., and Bianchi F. Anti-neuronal antibodies in patients with celiac disease and neurological disorders (abstr). Gastroenterology 124 (2003) A-15
28. Pittenger G.L., Liu D., and Vinik A.I. The toxic effects of serum from patients with type 1 diabetes mellitus on mouse neuroblastoma cells: a new mechanism for development of diabetic autonomic neuropathy. Diabet Med 10 (1993) 925-932
29. Pittenger G.L., Liu D., and Vinik A.I. The neuronal toxic factor in serum of type 1 diabetic patients is a complement-fixing autoantibody. Diabet Med 12 (1995) 380-386
30. Pittenger G.L., Liu D., and Vinik A.I. The apoptotic death of neuroblastoma cells caused by serum from patients with insulin-dependent diabetes and neuropathy may be Fas-mediated. J Neuroimmunol 76 (1997) 153-160
31. Srinivasan S., Stevens M.J., Sheng H., Hall K.E., and Wiley J.W. Serum from patients with type 2 diabetes with neuropathy induces complement-independent, calcium-dependent apoptosis in cultured neuronal cells. J Clin Invest 102 (1998) 1454-1462
32. De Giorgio R., Bovara M., Barbara G., Canossa M., Sarnelli G., De Ponti F., Stanghellini V., Tonini M., Cappello S., Pagnotta E., Nobile-Orazio E., and Corinaldesi R. Anti-HuD-induced neuronal apoptosis underlying paraneoplastic gut dysmotility. Gastroenterology 125 (2003) 70-79
33. Liu X., Kim C.N., Yang J., Jemmerson R., and Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome C. Cell 86 (1996) 147-157
34. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., and Wang X. Cytochrome C and dATP-dependent formation of Apaf-1/caspase-9 complex intiates an apoptotic protease cascade. Cell 91 (1997) 479-489
35. Zou H., Henzel W.J., Liu X., Lutschg A., and Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90 (1997) 405-413
36. Rosse T., Olivier R., Monney L., Rager M., Conus S., Fellay I., Jansen B., and Borner C. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 391 (1998) 496-499
37. Jurgensmeier J.M., Xie Z., Deveraux Q., Ellerby L., Bredesen D., and Reed J.C. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci U S A 95 (1998) 4997-5002
38. Du C., Fang M., Li Y., Li L., and Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102 (2000) 33-42
39. Oltvai Z.N., Milliman C.L., and Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolg, Bax, that accelerates programmed cell death. Cell 74 (1993) 609-619
40. Hsu Y.T., Wolter K.G., and Youle R.J. Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc Natl Acad Sci U S A 94 (1997) 3668-3672
41. Wolter K.G., Hsu Y.T., Smmith C.L., Nechushtan A., Xi X.G., and Youle R.J. Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 139 (1997) 1281-1292
42. Nagata S. Apoptosis by death factor. Cell 88 (1997) 355-365
43. Kroemer G., Petit P., Zamzami N., Vayssiere J.L., and Mignotte B. The biochemistry of programmed cell death. FASEB J 9 (1995) 1277-1287
44. Barrientos A., and Moraes C.T. Titrating the effects of mitochondrial complex I impairment in the cell physiology. J Biol Chem 274 (1999) 1688-1697